Bank Plus Trust Department Vertex Pharmaceuticals Inc Transaction History
Bank Plus Trust Department
- $305 Billion
- Q4 2024
A detailed history of Bank Plus Trust Department transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Bank Plus Trust Department holds 1,379 shares of VRTX stock, worth $648,640. This represents 0.18% of its overall portfolio holdings.
Number of Shares
1,379Holding current value
$648,640% of portfolio
0.18%Shares
1 transactions
Others Institutions Holding VRTX
# of Institutions
1,703Shares Held
221MCall Options Held
1.58MPut Options Held
1.36M-
Capital World Investors Los Angeles, CA26.8MShares$12.6 Billion1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.2MShares$10.9 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$10 Billion0.23% of portfolio
-
State Street Corp Boston, MA11.8MShares$5.56 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA9MShares$4.23 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $121B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...